Sera Prognostics (SERA) Share-based Compensation (2020 - 2026)
Sera Prognostics (SERA) posted Share-based Compensation of $835000.0 for Q1 2026, down 18.06% on a QoQ basis from $1.0 million in Q4 2025, and down 44.07% year-over-year from $1.5 million in Q1 2025.
Sera Prognostics (SERA) Share-based Compensation (2020 - 2026) Analysis & Trends
Sera Prognostics' Share-based Compensation history runs 7 years deep, the most recent figure standing at $835000.0 for Q1 2026.
- Quarterly Share-based Compensation fell 44.07% year-over-year to $835000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 34.65% YoY) and the FY2025 annual result came in at $5.1 million, down 27.14% from the prior year.
- Share-based Compensation was $835000.0 for Q1 2026 at Sera Prognostics, down from $1.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.0 million in Q2 2024 and bottomed at $835000.0 in Q1 2026.
- A 5-year average of $1.4 million and a median of $1.3 million in 2022 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 411.3% in 2022, while the deepest fall reached 87.22% in 2022.
- Sera Prognostics' Share-based Compensation stood at $1.3 million in 2022, then advanced by 0.45% to $1.3 million in 2023, then gained by 20.04% to $1.6 million in 2024, then plunged by 36.98% to $1.0 million in 2025, then declined by 18.06% to $835000.0 in 2026.
- Business Quant data shows SERA's Share-based Compensation at $835000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Sera Prognostics | 107.05 Mn | 107.05 Mn | -28,000.00 | 835,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 835,000.00 |
| Mar 31, 2026 | 835,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2023 | 1.35 Mn |